Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
Secure application of graphene in medicine. / Savicheva, Alevtina; Tapilskaya, Natalya; Spasibova, Elena; Gzgzyan, Alexander; Kogan, Igor; Shalepo, Kira; Vorobiev, Sergey; Kirichek, Ruslan; Pirmagomedov, Rustam; Rybin, Maxim; Glushakov, Ruslan.
в: Gynecological Endocrinology, Том 36, № S1, 2020, стр. 48-52.Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
}
TY - JOUR
T1 - Secure application of graphene in medicine
AU - Savicheva, Alevtina
AU - Tapilskaya, Natalya
AU - Spasibova, Elena
AU - Gzgzyan, Alexander
AU - Kogan, Igor
AU - Shalepo, Kira
AU - Vorobiev, Sergey
AU - Kirichek, Ruslan
AU - Pirmagomedov, Rustam
AU - Rybin, Maxim
AU - Glushakov, Ruslan
N1 - Publisher Copyright: © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group on behalf of the UR MED GRUPP (LLC). Copyright: Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020
Y1 - 2020
N2 - The unique physical properties considered of graphene to be especially perspective for photothermal therapy complex, drug address delivery to the target organs, and some other fields. Objective: The objective of our study was to explore the possible graphene impact on microorganism growth as well as on laboratory animal overall condition. Materials and technique: The experiments applied samples of graphene three concentrations and two 15 × 15 mm quartz glasses one of which carrying deposited graphene lattice. We have also used 5% blood agar, thioglycollate broth, bacterial suspensions of standard turbidity containing pure clinical isolate of microorganisms. Three white male 6-month-old laboratory rats were used to estimate the graphene impact on the overall animal condition. Results: Graphene did not contain any microorganisms, does not destroy erythrocytes placed within the artificial nutritional medium, graphene lattice did not add any properties to the quartz glasses which could allow the Proteus spread all over its surface. It was also established that graphene did not show any native antibacterial impact. No significant reaction was noticed in animals after graphene administration to laboratory rats neither at the injection spot nor at the overall level. Conclusion: Our data confirm the applicability of graphene both in scientific and practical biomedical purposes.
AB - The unique physical properties considered of graphene to be especially perspective for photothermal therapy complex, drug address delivery to the target organs, and some other fields. Objective: The objective of our study was to explore the possible graphene impact on microorganism growth as well as on laboratory animal overall condition. Materials and technique: The experiments applied samples of graphene three concentrations and two 15 × 15 mm quartz glasses one of which carrying deposited graphene lattice. We have also used 5% blood agar, thioglycollate broth, bacterial suspensions of standard turbidity containing pure clinical isolate of microorganisms. Three white male 6-month-old laboratory rats were used to estimate the graphene impact on the overall animal condition. Results: Graphene did not contain any microorganisms, does not destroy erythrocytes placed within the artificial nutritional medium, graphene lattice did not add any properties to the quartz glasses which could allow the Proteus spread all over its surface. It was also established that graphene did not show any native antibacterial impact. No significant reaction was noticed in animals after graphene administration to laboratory rats neither at the injection spot nor at the overall level. Conclusion: Our data confirm the applicability of graphene both in scientific and practical biomedical purposes.
KW - graphene, medicine, microorganisms, animal condition
UR - http://www.scopus.com/inward/record.url?scp=85097488479&partnerID=8YFLogxK
U2 - 10.1080/09513590.2020.1816717
DO - 10.1080/09513590.2020.1816717
M3 - Article
C2 - 33305673
AN - SCOPUS:85097488479
VL - 36
SP - 48
EP - 52
JO - Gynecological Endocrinology
JF - Gynecological Endocrinology
SN - 0951-3590
IS - S1
ER -
ID: 76492286